SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950142-22-001297
Filing Date
2022-04-05
Accepted
2022-04-05 16:08:26
Documents
12
Period of Report
2022-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh220241644_8k.htm   iXBRL 8-K 23275
  Complete submission text file 0000950142-22-001297.txt   196062

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vtvt-20220330.xsd EX-101.SCH 3054
3 XBRL LABEL FILE vtvt-20220330_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE vtvt-20220330_pre.xml EX-101.PRE 22609
6 EXTRACTED XBRL INSTANCE DOCUMENT eh220241644_8k_htm.xml XML 3612
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 22806841
SIC: 2834 Pharmaceutical Preparations